Quarterly report · Q3
7459.TEDINET S100SUGP
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.71T | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥3.36T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.57T | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥37.2bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥50.2bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥65.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥49.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥53.7bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥56.7bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥28.3bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥29.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥36.7bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥37.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥1.87T | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥1.71T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.81T | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.16T | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥1.02T | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥712.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥688.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥678.0bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥214.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥195.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥133.19 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.8 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥184.82 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥142.16 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.65 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥179.12 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.4 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥2.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥2.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥30m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥86.7bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥86.7bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥1m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥883.0bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥882.8bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥231m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥22.0bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.75T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.75T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥2.72T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥2.71T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥37.2bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | ¥44m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥848.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥847.9bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥253m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.67T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.66T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥37.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 385
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)塚原 克哲 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)御厨 健太郎 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)木村 純一 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 2567418000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 2714915000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 3360008000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 49908000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 50240000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 65122000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 29848000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 28286000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 38806000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 40986000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 40643000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 51084000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 677957000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 712572000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 688055000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 1807375000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 1873726000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1709658000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 142.16 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 133.19 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 184.82 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 136.40 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 179.12 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.306 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.310 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.328 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 59.65 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 52.80 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 221291342 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 221291342 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 221291342 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 221291342 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 11274000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 209826200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 2098262 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 191142 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 221291342 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 2098262 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 11274000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |